TARDBP and amyotrophic lateral sclerosis: A recent report by Rothstein and co-workers showed that rG2C4, but not rG4C2, targeting ASOs reduced TDP-43 pathology in C9 ALS patient induced pluripotent stem-cell (iPSC)derived neurons [167].